Effect of ACE inhibitors on the course of SARS-CoV-2 in a patient with pre-existing chronic kidney disease: a clinical case
The presence of in combination with hypertension stage 1–2 and its medical correction using renin-angiotensin-aldosterone system (RAAS) inhibitors significantly affects the health of patients who are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 uses RAAS as a tool to penetrate the cell, namely the receptor of angiotensin-converting enzyme (ACE) 2. The purpose of the work: to assess the dynamics of clinical and laboratory indicators in a patient with SARS-CoV-2-associated nephropathy against the background of taking ACE inhibitors. This article describes a clinical case from the author’s own practice. Timely prescription of etiotropic therapy for coronavirus disease 19 significantly reduces complications of chronic kidney disease course with hypertension..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Počki - 12(2023), 3, Seite 157-160 |
| Sprache: |
Englisch ; Ukrainisch |
|---|
| Beteiligte Personen: |
I.M. Zavalna [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Angiotensin-converting enzyme inhibitors |
|---|
| doi: |
10.22141/2307-1257.12.3.2023.419 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ096138106 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ096138106 | ||
| 003 | DE-627 | ||
| 005 | 20240413142738.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240413s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.22141/2307-1257.12.3.2023.419 |2 doi | |
| 035 | |a (DE-627)DOAJ096138106 | ||
| 035 | |a (DE-599)DOAJ3e50b49f5453496b9627883666b25fd9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a ukr | ||
| 050 | 0 | |a RC870-923 | |
| 100 | 0 | |a I.M. Zavalna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of ACE inhibitors on the course of SARS-CoV-2 in a patient with pre-existing chronic kidney disease: a clinical case |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The presence of in combination with hypertension stage 1–2 and its medical correction using renin-angiotensin-aldosterone system (RAAS) inhibitors significantly affects the health of patients who are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 uses RAAS as a tool to penetrate the cell, namely the receptor of angiotensin-converting enzyme (ACE) 2. The purpose of the work: to assess the dynamics of clinical and laboratory indicators in a patient with SARS-CoV-2-associated nephropathy against the background of taking ACE inhibitors. This article describes a clinical case from the author’s own practice. Timely prescription of etiotropic therapy for coronavirus disease 19 significantly reduces complications of chronic kidney disease course with hypertension. | ||
| 650 | 4 | |a sars-cov-2-associated nephropathy | |
| 650 | 4 | |a renin-angiotensin-aldosterone system | |
| 650 | 4 | |a angiotensin-converting enzyme inhibitors | |
| 650 | 4 | |a clinical case | |
| 650 | 4 | |a chronic kidney disease | |
| 653 | 0 | |a Diseases of the genitourinary system. Urology | |
| 773 | 0 | 8 | |i In |t Počki |d Zaslavsky O.Yu., 2017 |g 12(2023), 3, Seite 157-160 |w (DE-627)DOAJ000141941 |x 23071265 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:3 |g pages:157-160 |
| 856 | 4 | 0 | |u https://doi.org/10.22141/2307-1257.12.3.2023.419 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/3e50b49f5453496b9627883666b25fd9 |z kostenfrei |
| 856 | 4 | 0 | |u https://kidneys.zaslavsky.com.ua/index.php/journal/article/view/419 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2307-1257 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2307-1265 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 3 |h 157-160 | ||